CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 277 filers reported holding CLOVIS ONCOLOGY INC in Q2 2017. The put-call ratio across all filers is 0.51 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2018 | $33,677,000 | -35.4% | 1,146,636 | +0.0% | 1.55% | -23.0% |
| Q2 2018 | $52,128,000 | -15.3% | 1,146,436 | -1.7% | 2.01% | -31.7% |
| Q1 2018 | $61,559,000 | -18.2% | 1,165,884 | -34.4% | 2.94% | -39.7% |
| Q4 2017 | $75,260,000 | +16.2% | 1,777,884 | +126.3% | 4.88% | -2.9% |
| Q3 2017 | $64,742,000 | +391.4% | 785,700 | +458.4% | 5.02% | +202.0% |
| Q2 2017 | $13,174,000 | -42.2% | 140,700 | -70.7% | 1.66% | -42.9% |
| Q1 2017 | $22,791,000 | – | 479,700 | – | 2.91% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versant Venture Management, LLC | 814,833 | $45,630,648,000 | 43.63% |
| EcoR1 Capital, LLC | 384,348 | $21,523,000 | 10.89% |
| Palo Alto Investors LP | 2,102,857 | $117,760,000 | 6.91% |
| NEA Management Company, LLC | 2,279,781 | $127,668,000 | 6.19% |
| Redmile Group, LLC | 721,632 | $40,411,000 | 4.40% |
| Opaleye Management Inc. | 140,000 | $7,840,000 | 3.96% |
| CLIFTON PARK CAPITAL MANAGEMENT, LLC | 790,555 | $44,271,000 | 2.63% |
| SUFFOLK CAPITAL MANAGEMENT LLC | 339,327 | $19,002,000 | 2.31% |
| PFM Health Sciences, LP | 1,725,126 | $96,607,000 | 2.26% |
| HARBOURVEST PARTNERS LLC | 51,037 | $2,858,000 | 1.50% |